Navigation Links
Study highlights side effects felt by BRCA mutation carriers after cancer risk-reducing procedure
Date:5/30/2014

PHILADELPHIA The majority of women with cancer causing BRCA1 and BRCA2 mutations experience sexual dysfunction, menopausal symptoms, cognitive and stress issues, and poor sleep following prophylactic removal of their Fallopian tubes and ovaries - a procedure known as risk-reducing salpingo-oophorectomy (RRSO) - according to results of a new study from the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania. The team's findings, which reaffirm the need for a better understanding of how to manage long-term effects of the risk-reducing procedure, will be presented during the annual meeting of the American Society of Clinical Oncology in Chicago's McCormick Place on Saturday, May 31, 2014 (abstract #1508).

"These results reinforce the need for care providers to better understand and communicate with patients about the possible long-term effects of bilateral RRSO," said lead author Susan Domchek, MD, director of Penn's Basser Research Center for BRCA. "Removal of the Fallopian tubes and ovaries is associated with a decreased risk of death from breast and ovarian cancer for BRCA carriers, and is one of the most important interventions we have at the current time. However, this procedure comes with a price, so it's extremely important that clinicians work with women to help alleviate symptoms."

The new study surveyed 637 women with BRCA1 or BRCA2 mutations who had undergone the risk-reducing surgical procedure to have both ovaries and Fallopian tubes removed. Domchek and colleagues assessed participant quality-of-life through a series of questionnaires. Results show that suboptimal scores were present in the majority of patients for the majority of measures. Specifically, 73 percent reported sexual dysfunction, such as the absence of satisfaction and presence of pain; 61 percent had problems sleeping; 57 percent had symptoms of menopause such as hot flashes and vaginal dryness; and 56 percent had elevated levels of stress. Hormone replacement therapy did help mitigate symptoms, particularly in women undergoing oophorectomy prior to age 50.

Currently, it is recommended that BRCA1/2 mutation carriers undergo oophorectomy between ages 35-40 given the substantial benefits in decreasing breast and ovarian cancer risk and improving overall survival. "Our work highlights the need for novel strategies to prevent breast and ovarian cancer. Despite the efficacy of oophorectomy, given the negative impact, we need to continue to strive towards other options for prevention".


'/>"/>

Contact: Katie Delach
katie.delach@uphs.upenn.edu
215-349-5964
University of Pennsylvania School of Medicine
Source:Eurekalert

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. Study reveals how cancer drug causes diabetic-like state
3. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
4. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
5. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
6. No Added Cancer Risk From Hip Replacement Materials: Study
7. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
8. Early Study Finds Some Promise for Lung Cancer Vaccine
9. Narcissists Often Ace Job Interviews, Study Finds
10. Sexual objectification of female artists in music videos exists regardless of race, MU study finds
11. Soy may alleviate hot flashes in menopause, large-scale study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2020)... ... February 26, 2020 , ... Announcement ... Transposagen (now a Hera BioLabs company) which is best known for its commercialization ... CRISPR nickase systems as it is truly dimeric and demonstrates high fidelity with ...
(Date:2/23/2020)... MIAMI (PRWEB) , ... February 22, 2020 , ... ... “CSI: Crime Scene Investigation” Laurence Fishburne ( https://www.imdb.com/name/nm0000401/mediaindex ) is the host of ... about a large variety of topics affecting people across the country. A soon ...
(Date:2/21/2020)... Pa. (PRWEB) , ... February 21, 2020 , ... ... fat grafting or autologous fat transfer continues to garner traction as a viable ... released by Fact.MR, North America is predicted to remain the market leader ...
(Date:2/20/2020)... ... 20, 2020 , ... R3 Stem Cell, the nation's leader in regenerative therapies ... stem cell procedures on military veterans in 2019. The veterans traveled from ... the R3 Stem Cell Training Course for doctors , providers of all kinds learn ...
(Date:2/19/2020)... ... 2020 , ... The American College of Lifestyle Medicine (ACLM) ... Residency Curriculum (LMRC). The curriculum is the first comprehensive, applicable and flexible Lifestyle ... resident involvement, the curriculum has included residents in every aspect of its creation ...
Breaking Medicine News(10 mins):
(Date:2/21/2020)... PALO ALTO, Calif. (PRWEB) , ... February 21, 2020 , ... ... Analysis (ABA) solutions. The company is passionate about changing the lives of ... a grant consortium in California focused on helping people find employment opportunities. Special ...
(Date:2/20/2020)... (PRWEB) , ... February 20, 2020 , ... Enquire, a ... living and post-acute care, is proud to announce G5 as a Silver Sponsor of ... , “G5 is proud to return to Enquire Summit as a Silver Sponsor. This ...
(Date:2/19/2020)... ... , ... A new study released today in STEM CELLS Translational Medicine is ... a compressed spinal cord. It is also the first to show how transplanting basic ... enhances the injured spinal cord’s recovery. , The study, conducted on a rat ...
Breaking Medicine Technology: